Skip to main content
Fig. 3 | Alzheimer's Research & Therapy

Fig. 3

From: Identifying clinically useful biomarkers in neurodegenerative disease through a collaborative approach: the NeuroToolKit

Fig. 3

Fold change vs CU, Aβ42/Aβ40 amyloid-β negative with age <65 years. Aβ40, amyloid-β1–40; Aβ42, amyloid-β1–42; AD, Alzheimer’s disease; CU, cognitively unimpaired; GFAP, glial fibrillary acidic protein; IL, interleukin; MCI, mild cognitive impairment; NfL, neurofilament light; pTau, phosphorylated tau; sTREM2, soluble triggering receptor expressed on myeloid cells 2; tTau, total tau; YKL40, chitinase-3-like protein-1

Back to article page

Alzheimer's Research & Therapy

ISSN: 1758-9193